GlassScriptPhysician profile
Hunter L Brown
NPI 1831168913
$22,861.87
in general payments reported to CMS, 2019-2025
40 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,033 · 2020: $6,732 · 2021: $4,107 · 2022: $646 · 2023: $617 · 2024: $954 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,342.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ozark Cryosurgery, LLC | $18,312.00 | 2019-2021 | |
| Procept Biorobotics Corporation | $727.07 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $562.93 | 2019-2024 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $422.42 | 2019-2025 | Axonics |
| Organogenesis INC. | $374.47 | 2023-2025 | Puraply, Puraply Wound Matrix, Puraply Am |
| Sumitomo Pharma America, INC. | $244.65 | 2023-2025 | Orgovyx |
| Axonics, INC. | $223.93 | 2020-2023 | Axonics |
| Pfizer INC. | $193.96 | 2019-2025 | |
| Urogen Pharma, INC. | $190.54 | 2021-2025 | |
| Abbvie INC. | $188.00 | 2022-2025 | Lupron Depot |
| Coloplast Corp | $169.17 | 2020-2025 | |
| Janssen Biotech, INC. | $147.05 | 2019-2024 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $140.37 | 2020-2025 | |
| Myovant Sciences INC. | $134.62 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $106.46 | 2020-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $72.74 | 2023-2025 | Jatenzo, Eligard |
| Inspire Medical Systems, INC. | $62.00 | 2024-2025 | Inspire |
| Bk Medical Holding Company INC. | $57.62 | 2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Allergan, INC. | $51.19 | 2019 | |
| Blue Earth Diagnostics | $40.77 | 2021-2025 | Posluma |
| Kci USA, INC. | $39.04 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo |
| Progenics Pharmaceuticals, INC. | $36.66 | 2023-2024 | Pylarify |
| Tetraphase Pharmaceuticals, INC. | $34.57 | 2019 | |
| Myriad Genetic Laboratories, INC. | $30.90 | 2022 | |
| Tela Bio, INC. | $30.57 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $30.34 | 2021-2022 | |
| Neotract INC. | $27.37 | 2019 | |
| 180 Medical, INC. | $27.00 | 2024 | Gentlecath Glide |
| Cook Medical LLC | $22.59 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $20.13 | 2022 | |
| Covidien LP | $16.78 | 2019 | |
| Endo Pharmaceuticals INC. | $15.79 | 2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $15.11 | 2019 | |
| Z-Medica, LLC | $14.90 | 2019 | |
| Stryker Corporation | $14.70 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.56 | 2023 | |
| Medtronic USA, INC. | $12.81 | 2019 | |
| Innocoll Pharmaceuticals Limited | $12.46 | 2022 | |
| Amgen INC. | $12.20 | 2021 | |
| Acell, INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.